Adenosine phosphate
- Generic Name
- Adenosine phosphate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H14N5O7P
- CAS Number
- 61-19-8
- Unique Ingredient Identifier
- 415SHH325A
- Background
Adenosine phosphate, or adenylic acid, is an adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position. Adenosine phosphate was withdrawn by the FDA since it was considered neither safe nor effective for its intended uses as a vasodilator and an anti-inflammatory.
- Indication
For nutritional supplementation, also for treating dietary shortage or imbalance
- Associated Conditions
- -
- Associated Therapies
- -
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Colorado State University
- Target Recruit Count
- 9
- Registration Number
- NCT03738943
- Locations
- 🇺🇸
Human Performance and Clinical Research Laboratory, Fort Collins, Colorado, United States
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2015-10-16
- Lead Sponsor
- Zhujiang Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT02574975
- Locations
- 🇨🇳
Zhujiang Hospital, Guangzhou, Guangdong, China
Individual Differences in the Response to Drugs
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2016-11-29
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 28
- Registration Number
- NCT02485158
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath